Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > Positive News
View:
Post by hintonkid on Sep 01, 2021 11:41am

Positive News

Nice update this morning.  The FDA must be interested in continuing the review of the test if they asked the company to furnish them with additional data.  From any number of news sources, it looks like COVID tests are going to continue to be a normal part of life and I am sure that a significant number of testing outlets, from Universities, Schools, Workplaces, Clinics and the travel industry are going to be using these tests in the absence of proof of vaccination whether someone does not have a card or cell phone app or an individual has lost a card or other verification source.  I expect, as well, that there has been feedback, from testers and patients in regard to negative experiences with the invasive swab method of testing.  From the test being administered a bit roughly, by an inexperienced tester and leading to a patient leaving with a slightly bruised sinus  or a patient that has an adverse natural reflex to pull away when the swab is placed up in the nose.  If people have a choice of being able to spit into a test tube or having a swab placed up their nose I expect that they will definitely choose the spit test over the swab test.  Since THRM currently seems to be the only company, currently, with such a test available and just requiring final approval by the FDA it will likely see high demand for the test right out of the gate should the test be approved.
Comment by mooseslayer on Sep 01, 2021 11:55am
Because if their partnership, this us also traceable by employers, federal agencies etc
Comment by ClemFandango on Sep 01, 2021 2:55pm
The best part of the release: The Company expects its saliva-based COVID-19 antigen test to become the first rapid test to receive FDA-EUA approval. As AcuVid is an innovative, leading-edge rapid saliva test solution, additional information was required for the FDA-EUA review process.
Comment by beenthere on Sep 01, 2021 6:45pm
Yes I agree but .... ...the stock action today doesn't reflect that! I was very surprised we were not back over a $1! I guess you cannot rush greatness!  But I was very happy to read this news!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities